首页 | 本学科首页   官方微博 | 高级检索  
检索        

Effects of Gambogic Acid on the Regulation of Nucleoporin Nup88 in U937 Cells
作者姓名:舒文秀  陈燕  何静  崔国惠
作者单位:Institute of Hematology Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China,Wuhan 430022,China,Wuhan 430022,China,Wuhan 430022,China
摘    要:In order to investigate the anti-leukemia effects of gambogic acid (GA) and its relation to the regulation of nucleoporin Nup88 in U937 cells in vitro, the inhibitory effect of GA on the growth of U937 cells was examined by using MTT assay. Apoptosis was detected by Annexin-V FITC/PI double-labeled cytometry. Cell cycle regulation was studied by propidium iodide method. Both flow cytometry (FCM) and RT-PCR were employed to assess the expression of Nup88, and the localization of Nup88 was determined by confocal microscopy. The results indicated that GA had strong inhibitory effect on cell proliferation and apoptosis induction activity in U937 cells in vitro in a time-and dose-dependent manner. The 24-h IC50 value was (1.019±0.134) mg/L. Moreover, GA induced arrest of U937 cells in G0/G1 phase. Over-expression of Nup88 was found in U937 cells, whereas GA could significantly down-regulate both the protein and mRNA levels of Nup88. Nup88 was diffusely distributed between nucleus and cytoplasm and was located at the cytoplasmic side of nuclear rim, and occasionally in cytoplasm. It is suggested that GA exerts its anti-leukemia effects by regulating the expression and distribution of nucleoporin Nup88. It promises to be new agent for the treatment of acute leukemia.

关 键 词:Nup88  U937  氨基酸  急性白血病  细胞凋亡
收稿时间:29 March 2007
修稿时间:2007-03-29

Effects of gambogic acid on the regulation of nucleoporin Nup88 in U937 cells
Shu Wenxiu,Chen Yan,He Jing,Cui Guohui.Effects of Gambogic Acid on the Regulation of Nucleoporin Nup88 in U937 Cells[J].Journal of Zuazhong University of Science and Technology: Medical Edition,2007,27(4):388-392.
Authors:Shu Wenxiu  Chen Yan  He Jing  Cui Guohui
Institution:Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022,China
Abstract:Summary In order to investigate the anti-leukemia effects of gambogic acid (GA) and its relation to the regulation of nucleoporin Nup88 in U937 cells in vitro, the inhibitory effect of GA on the growth of U937 cells was examined by using MTT assay. Apoptosis was detected by Annexin-V FITC/PI double-labeled cytometry. Cell cycle regulation was studied by propidium iodide method. Both flow cytometry (FCM) and RT-PCR were employed to assess the expression of Nup88, and the localization of Nup88 was determined by confocal microscopy. The results indicated that GA had strong inhibitory effect on cell proliferation and apoptosis induction activity in U937 cells in vitro in a time-and dose-dependent manner. The 24-h IC50 value was (1.019±0.134) mg/L. Moreover, GA induced arrest of U937 cells in G0/G1 phase. Over-expression of Nup88 was found in U937 cells, whereas GA could significantly down-regulate both the protein and mRNA levels of Nup88. Nup88 was diffusely distributed between nucleus and cytoplasm and was located at the cytoplasmic side of nuclear rim, and occasionally in cytoplasm. It is suggested that GA exerts its anti-leukemia effects by regulating the expression and distribution of nucleoporin Nup88. It promises to be new agent for the treatment of acute leukemia. SHU Wenxiu, male, born in 1979, Graduate Student This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30472267).
Keywords:gambogic acid  acute leukemia  apoptosis  Nup88
本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号